From Generics to Genius: How AI is Transforming Indian Pharma
India has long been called the “pharmacy of the world.” From producing 60% of the globe’s vaccines to supplying affordable generic medicines to millions, Indian pharmaceutical companies have built a reputation for efficiency and reliability. Yet behind the statistics and manufacturing plants lies a quiet revolution, one driven not by manpower alone, but by artificial intelligence. Today, AI is shaping the way Indian pharma innovates, manages supply chains, personalizes care, and envisions the future of medicine.
In 2023, India ranked as the third-largest pharmaceutical producer by volume, accounting for 20% of global generic drug exports. According to IMARC Group, the market is projected to reach USD 174.31 billion by 2033, with AI adoption playing a pivotal role in achieving this growth.
Unlock the Future of Digital Health — Free for 60 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Subscribe Now @ ₹499.00Stay tuned for more such updates on Digital Health News
Follow us
